Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Derisomaltose in Obese Patients with Iron Deficiency
NCT07236788Recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Mar 2025
- Primary completion
- Dec 2026
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ferric derisomaltose in iron deficiency anemia (IDA) (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Changes in Hemoglobin concentration compared to baseline at 3 months. Started Mar 2025; status: recruiting.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT07236788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07236788.